Skip to content

Feasibility of a Multimodal Intervention Program to Optimize Treatment Outcomes in Ulcerative Colitis

OPTIMIZE-UC: Feasibility of a Multimodal Intervention Program to Optimize Treatment Outcomes in Ulcerative Colitis: A Prospective Pilot Study

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05743153
Acronym
OPTIMIZE-UC
Enrollment
30
Registered
2023-02-24
Start date
2023-10-01
Completion date
2024-10-01
Last updated
2023-09-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ulcerative Colitis

Brief summary

This is a prospective, interventional pilot study to assess the feasibility and optimal timing of a multimodal intervention program in Ulcerative Colitis (UC) patients with active disease as well as in patients in remission. Secondly, to demonstrate the effects of a multimodal intervention program on individual patients level and therapy outcomes.

Detailed description

Rationale: Despite considerable advances in the knowledge of UC, and a variation of treatment options, UC still impacts patients' ability to lead a normal life. Clearly, there is an unmet need to improve treatment outcomes. Prehabilitation programs in surgery have shown that the amount of complications is closely related to preoperative physical fitness, nutritional status and psychological well-being. IBD patients often search for self-management strategies to manage their symptoms, however, research focussing on a multimodal intervention approach in parallel to starting new IBD treatment is lacking. Given the potential benefits of intervention programs, limitations of current treatments in terms of improving quality of life and patients' desire for self-management options, we believe that exploring the results of a multimodal intervention program in patients with UC is of high relevance. Objective/study design: This is a prospective, interventional pilot study to assess the feasibility and optimal timing of a multimodal intervention program in UC patients. Secondly, to demonstrate the effects of a multimodal intervention program on individual patients level and therapy outcomes. Study population: Patients ≥ 18 years old, with UC. Intervention: Multimodal intervention program including an exercise program, nutritional intervention and psychological evaluation. Main study parameters/endpoints: This study assesses the feasibility of a multimodal intervention program. Secondary, assesses the effect on: * Individual patients' level, i.e. physical fitness, nutritional status, mental health, quality of life and work productivity and activity impairment. * Therapy outcomes, e.g. adherence, number and severity of (S)AEs, corticosteroid use, biochemical and clinical response/remission rates and patient reported outcomes.

Interventions

Exercise intervention: combined endurance and resistance training three times a week using workout video's which patients can do at home. Advice to exercise at low-intensity for at least 30 minutes per day. Nutritional intervention: Patients are advised to aim for optimal energy and protein intake (by registered dietician) and to avoid red meat, processed foods and sweetened drinks. Aiming for a mainly plant based diet. Psychological intervention: screening for psychological risk factors and if present, patients are referred to a psychologist for psychological support.

Sponsors

Radboud University Medical Center
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age ≥ 18 years old; * Diagnosis of UC confirmed by clinical, endoscopic, and/or histological evidence prior to screening as per standard criteria; * Ability of subject to participate fully in all aspects of this project; * Written informed consent must be obtained and documented.

Exclusion criteria

* Suspicion of differential diagnosis of CD, indeterminate colitis, ischemic colitis, radiation colitis, diverticular disease associated with colitis, or microscopic colitis; * Serious underlying disease other than UC that in the opinion of the investigator may interfere with the subject's ability to participate fully in the study or would compromise subject safety (such as history of malignancies, major neurological disorders, certain orthopedic impairments or any unstable, uncontrolled or severe systemic medical disorder); * History of alcohol or drug abuse that in the opinion of the investigator may interfere with the subject's ability to comply with the study procedures; * History of psychiatric disorders that in the opinion of the investigator may interfere with the subject's ability to comply with the study procedures; * If female, the subject is pregnant or lactating (\< 1 year) or intending to become pregnant; * Immobilized patients who are not able to complete exercise intervention; * Illiteracy (disability to read and understand Dutch).

Design outcomes

Primary

MeasureTime frameDescription
Accrural24 weeksThe percentage of approached, eligible participants that are included in the study.
Attrition24 weeksThe percentage of participants who stopped the program prematurely.
Adherence to exercise program24 weeksFrequency of followed trainings
Adherence to daily exercise goals24 weeksSQUASH questionnaire
Satisfaction24 weeksMeasured using a patient satisfaction questionnaire
Safety24 weeksMeasured by the number of adverse events occurring during the program

Secondary

MeasureTime frameDescription
Change in Work Productivity and Activity Impairment1 yearWork Productivity and Activity Impairment Questionnaire (including WPAI-GH)
Change in 36-Item Short Form Health Survey (SF-36) score1 yearQuality of life
Change in Oxygen Consumption (VO2 max)1 yearIndication of physical fitness
Change in Inflammatory Bowel Disease Questionnaire score1 yearDisease-related quality of life
Change in EuroQoL (EQ-5D-5L) score1 yearQuality of life
Change in 1 repitition measures1 yearIndication of muscle strength
Change in body weight1 yearMeasured in kilograms
Change in fat-free mass1 yearMeasured with bioelectrical impedance analysis (BIA)
Change in nutritional status1 yearMeasured with Patient Generated Subjective Global Assessment (PG-SGA)
Change in mental health1 yearHospital Anxiety and Depression scale (HADS questionnaire)

Countries

Netherlands

Contacts

Primary ContactDorien Oomkens
dorien.oomkens@radboudumc.nl+31650084590

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026